[1]何 蕊,程玉峰,李艳彬.射干麻黄汤加减对支气管哮喘疗效及患者炎症反应的影响[J].陕西中医,2021,(9):1211-1214.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.015]
　HE Rui,CHENG Yufeng,LI Yanbin.Effect of modified Shegan Mahuang decoction on bronchial asthma and inflammation[J].,2021,(9):1211-1214.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.015]
点击复制

射干麻黄汤加减对支气管哮喘疗效及患者炎症反应的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年9期
页码:
1211-1214
栏目:
临床研究
出版日期:
2021-09-05

文章信息/Info

Title:
Effect of modified Shegan Mahuang decoction on bronchial asthma and inflammation
作者:
何 蕊; 程玉峰; 李艳彬
(亳州市中医院肺病科,安徽 亳州 236800)
Author(s):
HE Rui; CHENG Yufeng; LI Yanbin
(Department of Pulmonary Disease,Bozhou Hospital of Traditional Chinese Medicine,Bozhou 236800,China)
关键词:
支气管哮喘;  射干麻黄汤;  炎症反应;  证候积分;  安全性
Keywords:
Bronchial asthma;  Shegan Mahuang decoction;  Inflammatory response;  Syndrome score;  Security
分类号:
R 256.12
DOI:
DOI:10.3969/j.issn.1000-7369.2020.09.015
文献标志码:
A
摘要:
目的:研究射干麻黄汤加减治疗支气管哮喘疗效及对患者炎症反应的影响。方法:选取98例支气管哮喘患者为研究对象,采用随机数字表法分为对照组(n=46)和观察组(n=52),对照组给予常规西药治疗,观察组在对照组基础上给予射干麻黄汤加减治疗。比较两组临床疗效、中医证候积分、白细胞计数(WBC)、嗜酸性粒细胞百分比(EOS)、中性粒细胞百分比(N)、C反应蛋白(CRP)、降钙素原(PCT)、血沉、呼出气一氧化氮(FeNO)、免疫球蛋白E(IgE)及不良反应发生率。结果:观察组患者总有效率92.00%高于对照组患者的73.91%,差异有统计学意义(P<0.05)。治疗后两组患者中医证候积分、WBC、EOS、N、CRP、PCT、血沉、FeNO、IgE均较治疗前降低,且观察组患者低于对照组,差异有统计学意义(均P<0.05)。两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。结论:射干麻黄汤加减联合西药治疗支气管哮喘疗效较好,可有效缓解临床症状,抑制炎症反应,且安全性较高。
Abstract:
Objective:To study clinical efficacy of modified Shegan Mahuang decoction in treatment of patients with bronchial asthma and its influence on inflammatory factors.Methods:A total of 98 patients with bronchial asthma were divided into control group(n=46)and observation group(n=52)by random number table method.The control group was treated with routine western medicine,while the observation group was treated with modified Shegan Mahuang decoction on basis of the control group.Clinical efficacy,TCM syndrome score,white blood cell count(WBC),percentage of eosinophils(EOS),percentage of neutrophils(N),C-reactive protein(CRP),procalcitonin(PCT),erythrocyte sediuration,exhaled nitric oxide(FeNO),immunoglobulin E(IgE)and incidence of adverse reactions were compared between the two groups.Results:The total efficiency 92.00% in the observation group was higher than 73.91% in the control group,difference statistically significant(P<0.05).After treatment,TCM syndrome scores,WBC,EOS,N,CRP,PCT,erythrocyte sedimentation rate,FeNO and IgE in both groups were lower than those in the control group,and the above indicators in the observation group were lower than those in the control group,difference statistically significant(all P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Modified Shegan Mahuang decoction combined with western medicine in the treatment of patients with bronchial asthma has significant efficacy,alleviate clinical symptoms,inhibit inflammatory response,and better safety.

参考文献/References:

[1] 梁彩艳.气道高反应性与儿童支气管哮喘上下气道炎症相关性研究[J].陕西医学杂志,2018,47(10):1240-1242.
[2] 谢刚强,唐 甦,马军党,等.噻托溴铵联合大剂量沙美特罗氟替卡松治疗重度支气管哮喘合并COPD稳定期疗效研究[J].陕西医学杂志,2018,47(7):931-933,936.
[3] 叶三霞.清肺汤加减对痰湿蕴肺型支气管哮喘缓解期患者免疫细胞的调节作用研究[J].四川中医,2018,36(5):91-94.
[4] 马红霞,罗建江.加减三子养亲汤辅助治疗支气管哮喘对患者肺功能及气道重塑的影响[J].世界中医药,2018,13(9):57-60.
[5] 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南[J].中华结核和呼吸杂志,2020,43(12):1023-1048.
[6] 李国锐.中医病证诊断疗效标准[M].南京:南京大学出版社,1995:131-133.
[7] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:102-104.
[8] 杨 永,徐靖华,金 巍,等.化痰活血通络方对支气管哮喘患者临床症状炎性因子以及肺功能的影响[J].解放军医药杂志,2019,31(9):91-94.
[9] 李 欣.三拗汤加减治疗支气管哮喘急性发作(寒哮证)的临床观察[J].中国中医急症,2018,27(8):1420-1422.
[10] 冷 静,王艳梅,李 慧,等.理肺化瘀方治疗支气管哮喘疗效及对患者血清内IGG、IGA、IGM的变化研究[J].陕西中医,2020,41(5):618-620.
[11] 段元元,吕 健,王志飞,等.喘可治注射液雾化吸入治疗支气管哮喘的有效性及安全性的系统评价[J].世界中医药,2021,16(2):268-273.
[12] 戚凯文,郑文松,李孟辉,等.百令胶囊联合吸入性糖皮质激素治疗儿童支气管哮喘临床观察[J].山东医药,2021,61(4):76-79.
[13] 陈书文.黄芪注射液联合西药对支气管哮喘患者气道重塑及肺功能状态的影响研究[J].陕西中医,2017,38(5):647-649.
[14] 王聪慧,周哲屹.射干麻黄汤联合沙丁胺醇对哮喘(冷哮)患者YKL-40及肺功能的影响[J].中药材,2019,42(7):226-228.
[15] 陈 宏,宋瑜欣,于晓华,等.射干麻黄汤加减联合脾多肽注射液对小儿咳嗽变异性哮喘的免疫功能影响及临床疗效观察[J].安徽医药,2019,23(4):188-191.
[16] 陈华侨,王宝珍.射干麻黄汤治疗小儿咳嗽变异性哮喘的疗效及对血清IGE、IL-4、TNF-α水平的影响[J].陕西中医,2017,38(10):1358-1360.
[17] 喻 敏,王慧敏,王少飞,等.加味射干麻黄汤对重度支气管哮喘患者血清ECP、LPO、FENO及肺功能的影响[J].现代生物医学进展,2018,24(17):331-335.
[18] 陈 豪,陈军红,沈旭波,等.射干麻黄汤对哮喘性肺炎大鼠肺部炎症反应及免疫反应的影响[J].广州中医药大学学报,2020,37(2):317-323.
[19] 任红芳,罗 燕,杨玉凤,等.经方射干麻黄汤配合氨溴特罗治疗感染后咳嗽(风寒恋肺证)疗效及对中医证候积分和神经源性气道炎症介质的影响[J].中国中医急症,2019,28(2):86-89.
[20] 徐贵华,史苗颜,宋秀明,等.射干麻黄汤加味治疗支气管哮喘冷哮证的临床观察[J].北京中医药,2017,33(4):12-15.
[21] 成小蓉,杜 丽.射干麻黄汤加减联合布地奈德对寒痰郁肺型小儿毛细支气管炎患者治疗效果观察[J].中国中医基础医学杂志,2019,25(8):90-93,126.
[22] 李翠玉,邹 营.射干麻黄汤治疗咳嗽变异性哮喘的疗效及其对免疫系统的干预效应[J].世界中医药,2018,13(10):2514-2517.
[23] 陈 宏,宋瑜欣,于晓华,等.射干麻黄汤加减联合脾多肽注射液对小儿咳嗽变异性哮喘的免疫功能影响及临床疗效观察[J].安徽医药,2019,23(4):188-191.
[24] 隋博文,王 达,翟平平,等.射干麻黄汤对哮喘小鼠气道重塑及TH17/CD4+CD25+TREG细胞的影响及机制研究[J].中国中医急症,2017,26(2):204-207.
[25] 聂清华,范伏元.射干麻黄汤联合沙丁胺醇对慢性阻塞性肺疾病患者肺功能、生活质量的影响[J].陕西中医,2020,41(2):180-182.

相似文献/References:

[1]吕明辉,贾艳平,元国红.清热涤痰定喘汤联合穴位贴敷治疗儿童支气管哮喘安全性及疗效分析[J].陕西中医,2019,(1):25.
　LV Minghui,JIA Yanping,YUAN Guohong..Safety and efficacy of Qingre Ditan Dingchuan decoction combined with acupoint sticking in the treatment of bronchial asthma in children[J].,2019,(9):25.
[2]李红芬,毕玲莉,张茂华.小青龙汤联合糖皮质激素对支气管哮喘患儿气道重塑 及相关炎症因子的影响[J].陕西中医,2019,(5):631.
　LI Hongfen,BI Lingli,ZHANG Maohua..Effects of Xiaoqinglong decoction combined with glucocorticoid on airway remodeling and related inflammatory factors in children with bronchial asthma[J].,2019,(9):631.
[3]唐徐韵,陈盼碧△.穴位埋线治疗支气管哮喘的实验研究探讨*[J].陕西中医,2019,(12):1789.
[4]聂清华,范伏元△.射干麻黄汤联合沙丁胺醇对慢性阻塞性肺疾病患者肺功能、生活质量的影响[J].陕西中医,2020,(2):180.
　NIE Qinghua,FAN Fuyuan..Effects of Shegan Mahuang decoction and albuterol on pulmonary function and quality of life in patients with COPD[J].,2020,(9):180.
[5]冷 静,王艳梅,李 慧△.理肺化瘀方治疗支气管哮喘疗效及对患者血清内IgG、IgA、IgM的变化研究*[J].陕西中医,2020,(5):618.[doi:DOI:10.3969/j.issn.10007369.2020.05.018]
　LENG Jing,WANG YanMei,LI Hui..Lifei Huayu decoction in the treatment of bronchial asthma and the change of serum IgG,IgA,IgM in patients[J].,2020,(9):618.[doi:DOI:10.3969/j.issn.10007369.2020.05.018]
[6]王兰香,李卫红,周 瑾,等.消积豁痰汤加减联合糖皮质激素治疗老年支气管哮喘临床研究[J].陕西中医,2021,(6):724.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.011]
[7]高 辉,刘 恭,韩仙菊.黄芩素上调miR-625-5p表达干预支气管哮喘小鼠的机制研究[J].陕西中医,2022,(7):838.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.005]
　GAO Hui,LIU Gong,HAN Xianju.The mechanism of baicalein up-regulating miR-625-5p expression in bronchial asthma mice[J].,2022,(9):838.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.005]
[8]孟玲玉,黄 燕,包海鹏,等.加味过敏煎对支气管哮喘大鼠嗜酸性粒细胞凋亡及Fas、Bcl-2调节作用的研究[J].陕西中医,2023,(5):562.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.004]
　MENG Lingyu,HUANG Yan,BAO Haipeng,et al.Research of Jiawei Guomin decoction on eosinophil apoptosis and the regulation mechanism of Fas,Bcl-2 in bronchial asthma rats[J].,2023,(9):562.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.004]
[9]王 伟,马丽华,鞠 上.投杯汤治疗支气管哮喘疗效及对患者气道重塑和气道炎症的影响[J].陕西中医,2023,(8):1047.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.011]
　WANG Wei,MA Lihua,JU Shang.Effect of Toubei decoction on bronchial asthma and its influence on airway remodeling and inflammation[J].,2023,(9):1047.[doi:DOI:10.3969/j.issn.1000-7369.2023.08.011]
[10]季雅楠,田春燕,郭丹丹,等.基于PI3K/Akt信号通路探讨中医药治疗支气管哮喘研究进展[J].陕西中医,2023,(12):1827.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.036]
　JI Yanan,TIAN Chunyan,GUO Dandan,et al.Progress in the treatment of bronchial asthma with traditional Chinese medicine based on PI3K/Akt signaling pathway[J].,2023,(9):1827.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.036]

备注/Memo

备注/Memo:
基金项目:安徽省自然科学基金资助项目(1408085MH169)
更新日期/Last Update: 2021-09-10